BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28930282)

  • 1. Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.
    Testa U; Castelli G; Pelosi E
    Medicines (Basel); 2017 Sep; 4(3):. PubMed ID: 28930282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma.
    Panda A; Bhanot G; Ganesan S; Bajpai M
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy.
    Zhang X; Wang Y; Meng L
    Acta Pharm Sin B; 2022 Mar; 12(3):1054-1067. PubMed ID: 35530133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
    Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
    Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress of cancer stem cells and IL-6/STAT3 signaling pathway in esophageal adenocarcinoma.
    Chen M; Ye X; Wang R; Poon K
    Transl Cancer Res; 2020 Jan; 9(1):363-371. PubMed ID: 35117190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.
    Duggan SP; Garry C; Behan FM; Phipps S; Kudo H; Kirca M; Zaheer A; McGarrigle S; Reynolds JV; Goldin R; Kalloger SE; Schaeffer DF; Long A; Strid J; Kelleher D
    Cell Mol Gastroenterol Hepatol; 2018; 5(4):569-590. PubMed ID: 29930979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.
    Liu S; Dai JY; Yao L; Li X; Reid B; Self S; Ma J; Chang Y; Feng S; Tapsoba Jde D; Sun X; Sun X
    PLoS One; 2014; 9(10):e110348. PubMed ID: 25333822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
    Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
    Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
    Jin Z; Olaru A; Yang J; Sato F; Cheng Y; Kan T; Mori Y; Mantzur C; Paun B; Hamilton JP; Ito T; Wang S; David S; Agarwal R; Beer DG; Abraham JM; Meltzer SJ
    Clin Cancer Res; 2007 Nov; 13(21):6293-300. PubMed ID: 17975140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?
    von Rahden BH; Kircher S; Lazariotou M; Reiber C; Stuermer L; Otto C; Germer CT; Grimm M
    J Exp Clin Cancer Res; 2011 Feb; 30(1):23. PubMed ID: 21345220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in oesophageal diseases.
    Al Dulaimi D
    Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status and Future Prospects for Esophageal Cancer.
    Sheikh M; Roshandel G; McCormack V; Malekzadeh R
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype.
    Okada M; Ishimura N; Mikami H; Okimoto E; Oshima N; Miyaoka Y; Fujishiro H; Ishihara S; Kinoshita Y
    Esophagus; 2019 Jan; 16(1):98-106. PubMed ID: 30145681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma.
    Hoppe S; Jonas C; Wenzel MC; Velazquez Camacho O; Arolt C; Zhao Y; Büttner R; Quaas A; Plum PS; Hillmer AM
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.
    Liu D; Wen J; Chen J; Wang B; Xu X; Zhang Z; Fan M
    Front Surg; 2021; 8():655159. PubMed ID: 34395507
    [No Abstract]   [Full Text] [Related]  

  • 18. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
    Booka E; Tsubosa Y; Yokota T; Mayanagi S; Ishii K; Urakami K; Ohshima K; Ohnami S; Nagashima T; Yamaguchi K
    Esophagus; 2021 Oct; 18(4):743-752. PubMed ID: 33826001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.
    Li X; Wang Y; Min Q; Zhang W; Teng H; Li C; Zhang K; Shi L; Wang B; Zhan Q
    Comput Struct Biotechnol J; 2023; 21():3841-3853. PubMed ID: 37564101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.